Stay updated on Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Footer revision updated from Revision: v3.4.2 to Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:15:34.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision updated to v3.4.2 and the prior funding/operating-status notice was removed; these are site-wide housekeeping changes rather than updates to study details.
    Difference
    0.4%
    Check dated 2026-02-11T14:30:10.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and the system revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:46:36.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added: Show glossary toggle; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Deleted: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T06:29:14.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page, with no evident changes to study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:28:39.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The Locations section is reorganized into a consolidated 'Locations' block with added provinces (Beijing Municipality, Hebei, Heilongjiang, Hunan, Jilin, Shanxi, Sichuan), replacing the former province-specific location headings. The revision version updated from v3.3.2 to v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-23T20:25:32.000Z thumbnail image

Stay in the know with updates to Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page.